Unprecedented Inserm Study on Doping Reveals Complex Health Impacts, Amateur Athletes at Risk

Paris, France — April 24, 2026 — In a landmark assessment released Friday, twelve experts from France’s National Institute of Health and Medical Research (Inserm) unveiled the findings of the first-ever collective expert analysis dedicated exclusively to doping in sports. After meticulously reviewing thousands of scientific articles, the panel concluded that quantifying the true scale of doping remains highly complex, health consequences are often unclear, and amateur athletes are significantly affected — challenging long-held assumptions about performance-enhancing drug apply.

The study, conducted under Inserm’s collective expert evaluation framework, represents a significant departure from previous doping research by synthesizing evidence across medical, ethical, and social dimensions rather than focusing solely on elite athletes or detection methodologies. According to the Inserm announcement, the expert panel worked for over a year to evaluate the current state of knowledge on substances and methods prohibited by the World Anti-Doping Agency (WADA).

Measurement Challenges Complicate Doping Prevalence Estimates

One of the central findings highlights the extreme difficulty in accurately measuring how widespread doping actually is. The experts noted that existing estimates vary dramatically depending on the sport, detection methods used, and populations studied — ranging from anonymous surveys to biological passport data. This variability makes it nearly impossible to establish a reliable global prevalence figure, the report states.

The panel emphasized that traditional testing programs likely capture only a fraction of actual use, particularly for substances designed to evade detection or used in micro-dosing regimens. Significant disparities exist between professional and amateur sporting environments, where testing protocols differ vastly in frequency and sophistication.

Health Effects Remain Poorly Understood Despite Widespread Use

Perhaps most concerning to the experts was the limited understanding of long-term health consequences associated with many performance-enhancing substances. While short-term effects of certain drugs like anabolic steroids or erythropoietin (EPO) are relatively well-documented, the panel found substantial gaps in knowledge regarding:

• Cumulative damage from prolonged use of multiple substances
• Health impacts of newer compounds like selective androgen receptor modulators (SARMs)
• Interactions between different doping agents
• Effects on developing bodies in adolescent athletes
• Psychological dependence and mental health outcomes

The experts specifically called for increased investment in longitudinal studies tracking athletes’ health over decades, particularly focusing on recreational users who may lack access to medical supervision. They noted that current research disproportionately focuses on elite athletes or clinical populations, leaving a critical blind spot regarding the majority of people who use these substances outside competitive sports.

Amateur Athletes Face Underestimated Risks

A key revelation of the Inserm analysis is that amateur and recreational athletes constitute a significant portion of doping users — a demographic often overlooked in anti-doping policy discussions. The experts cited evidence suggesting that in some fitness and bodybuilding communities, prevalence rates may rival or exceed those seen in certain professional sports.

This finding raises serious public health concerns, as amateur users typically:

• Obtain substances through unregulated online markets
• Lack medical supervision during use
• Combine multiple compounds without understanding interactions
• Have limited access to harm reduction information

The panel warned that this creates a hidden epidemic of substance use with potentially severe consequences for liver function, cardiovascular health, and endocrine systems — particularly given that many users begin experimenting in their late teens or early twenties.

Experts Call for Shift from Punitive to Health-Centered Approach

Beyond documenting the complexities of doping, the Inserm panel advocated for a fundamental rethinking of how societies address performance-enhancing substance use. Rather than relying primarily on sanctions and testing — which the experts acknowledged have limited deterrent effect — they recommended integrating doping prevention into broader public health and sports medicine frameworks.

Specific proposals included:

• Improving education programs for coaches and trainers in amateur sports
• Expanding access to confidential health counseling for athletes considering or using substances
• Developing clearer guidelines for medical professionals encountering doping-related health issues
• Investing in research on effective harm reduction strategies
• Creating safer pathways for athletes seeking to discontinue use

Global Implications for Sports Governance

While conducted by a French research body, the findings carry significant weight for international sports governance. The experts noted that current anti-doping systems, largely built around detecting and punishing elite athletes, fail to address the root causes of substance use or protect the growing number of non-competitive users.

They suggested that organizations like WADA and international federations should consider:

• Supporting research into prevalence among recreational athletes
• Collaborating with public health agencies on education campaigns
• Exploring alternative models that prioritize health outcomes over punishment
• Involving athletes themselves in designing prevention strategies

Next Steps and Ongoing Research

The Inserm expert panel emphasized that their report represents a starting point, not a conclusion. They identified several priority areas for immediate research attention, including:

• Standardizing methodologies for estimating doping prevalence across different contexts
• Creating international databases tracking long-term health outcomes of former users
• Evaluating the effectiveness of various prevention interventions
• Examining cultural and motivational factors driving substance use in amateur settings

French Minister of Health and Sports is expected to respond to the findings in the coming weeks, with potential implications for national sports policy and funding allocations for research and prevention programs.

For athletes, coaches, and sports medicine professionals seeking reliable information on performance-enhancing substances and their risks, Inserm maintains updated resources through its dedicated sports medicine research unit. The full expert report is available through Inserm’s official publications portal.

What are your thoughts on balancing anti-doping efforts with athlete health support? Share your perspective in the comments below, and help spread awareness by sharing this article with your sporting community.